Table 3.
Hypermobility (N=36) (Beighton score≥4) | Non-hypermobility (N=244) (Beighton score<4) | P Value | |
---|---|---|---|
Age, years | 53.27±14.38 | 56.36±14.64 | 0.24 |
BMI (kg/m2) | 29.67±6.09 | 31.23±6.67 | 0.19 |
Female % | 83.3% (n=30) | 66.4% (n=162) | |
Joint self-reported symptoms | N (% of group of 25 total) | N (% of group of 224 total) | |
Hand symptoms | 1 (4.0%) | 47 (21.0%) | 0.02 |
Knee symptoms | 5 (20.0%) | 92 (41.1%) | 0.03 |
Hip symptoms | 5 (20.0%) | 43 (19.2%) | 0.92 |
Spine symptoms | 12 (48.0%) | 101 (45.1%) | 0.78 |
Ankle symptoms | 4 (16.0%) | 38 (17.0%) | 0.90 |
Shoulder symptoms | 7 (28.0%) | 68 (30.4%) | 0.80 |
Elbow symptoms | 2 (8.0%) | 23 (10.3%) | 0.71 |
Wrist symptoms | 3 (12.0%) | 30 (13.4%) | 0.84 |
Big toes | 2 (8%) | 16 (7.1%) | 0.87 |
For evaluation of age and BMI between hypermobility and non-hypermobility groups, P value was generated by unpaired t test
For evaluation of symptoms between hypermobility and non-hypermobility groups, P value was generated by Likelihood ratio Chi-square for joint self-reported symptoms